Introduction: Biological individuality versus carbohydrate

For decades, official nutritional recommendations have treated carbohydrates as a homogeneous group of macronutrients that should constitute between 45% and 55% of the daily caloric intake of any healthy adult. However, clinical practice and daily scientific research reveal a completely different picture. Two people of the same age, sex, and activity level can consume the same amount of carbohydrates (for example, a cup of brown rice) and experience radically different metabolic responses. While one maintains stable blood glucose levels and excellent postprandial energy, the other suffers severe hyperglycemic spikes, drowsiness, and reactive hypoglycemia that stimulates the storage of body fat.

The answer to this great paradox lies not only in willpower or body composition, but also in variations within our genetic code. Single nucleotide polymorphisms (SNPs) dramatically alter the rate at which we digest starches, the efficiency with which our pancreas secretes insulin, the sensitivity of our cell receptors, and how the brain processes satiety signals in response to sugar intake. Synchronizing carbohydrate intake and type with our genetic map is at the heart of modern nutrigenetics and the key to optimizing long-term metabolic health.

The dogma of the glycemic index and its limitations

The glycemic index (GI) has traditionally been the gold standard for classifying carbohydrates according to their ability to raise blood glucose. However, this model assumes that a food's GI is a fixed and unchanging property. Pioneering studies in personalized nutrition, such as the PREDICT project led by King's College London, have demonstrated that interindividual postprandial variability is so immense that a food considered "low glycemic index" for one person can trigger a severe hyperglycemic response in another, strongly influenced by their genetic makeup and gut microbiota. This shows that generic recommendations based on static GI tables are outdated and that the response to carbohydrates is a biologically defined individual characteristic.

Variations in the salivary amylase gene (AMY1) and starch digestion

The digestion of complex carbohydrates (starches) begins long before they reach the stomach. The first enzymatic step occurs in the oral cavity through the salivary amylase enzyme, encoded by the AMY1 gene. Unlike most human genes, which consist of two copies (one from the mother and one from the father), the AMY1 gene exhibits extraordinary structural variation known as copy number variation (CNV), allowing individuals to have anywhere from 2 to more than 15 copies of the gene.

Metabolic implications of AMY1 copy number

The number of copies of the AMY1 gene directly determines the amount of amylase enzyme secreted in saliva. Individuals with a high copy number (e.g., more than 8 copies) digest starch extremely efficiently in the mouth, rapidly breaking it down into simple sugars. This results in a quick release of glucose and an early insulin response, which helps maintain stable blood glucose levels.

Conversely, individuals with a low number of AMY1 copies (e.g., fewer than 4 copies) exhibit very slow oral digestion of starch. This results in starch reaching the small intestine virtually intact, where its delayed digestion is associated with inefficient glycemic clearance, a greater inflammatory response, and a significantly higher predisposition to developing obesity and insulin resistance on diets rich in refined carbohydrates. Understanding the AMY1 genotype is vital for determining whether a patient should prioritize simple or complex carbohydrates, or reduce the overall glycemic load of their diet.

The TCF7L2 gene: The predisposition to insulin resistance and GLP-1 secretion

The TCF7L2 gene (Transcription Factor 7 Like 2) is currently the most potent known genetic risk factor for the development of type 2 diabetes. This gene encodes a transcription factor that plays a critical role in the Wnt signaling pathway, which regulates the development and function of pancreatic beta cells, responsible for the production and secretion of the hormone insulin.

Diet-genotype interaction in carriers of the risk variant

Polymorphisms in the TCF7L2 gene, specifically the T allele of the rs7903146 SNP, substantially impair the pancreas's ability to secrete insulin in response to glucose and decrease the production of the satiety hormone GLP-1 (glucagon-like peptide-1) in intestinal L cells. Carriers of this risk allele experience an inefficient metabolic response after consuming high-glycemic-index carbohydrates, suffering prolonged postprandial hyperglycemia due to delayed and insufficient insulin secretion.

However, nutrigenetics demonstrates that genetic destiny is not predetermined. Clinical studies reveal that when carriers of the TCF7L2 risk allele consume a Mediterranean diet rich in monounsaturated fats (such as those found in extra virgin olive oil) and low in simple carbohydrates, their risk of developing insulin resistance and type 2 diabetes decreases dramatically, becoming comparable to that of individuals without the risk variant. Nutritional personalization allows for the identification of these individuals in order to implement precision dietary modulation strategies that proactively protect their pancreatic function.

The fat mass and obesity (FTO) gene and postprandial satiety

The FTO (Fat Mass and Obesity-Associated) gene is widely known for its involvement in regulating food intake and energy expenditure. This gene is strongly expressed in the hypothalamus, the brain region that controls hunger, satiety, and preference for specific macronutrients.

Modulation of the carbohydrate response according to the FTO genotype

The most studied polymorphism of this gene is rs9939609, where the presence of the A allele is associated with a higher body mass index and obesity. At the molecular level, carriers of the A allele exhibit abnormally high circulating levels of ghrelin (the hunger hormone) after food intake, and reduced attenuation of hunger signals in the brain.

When it comes to carbohydrates, individuals with the AA or AT risk genotype show a natural preference for foods high in simple sugars and saturated fats, and experience less postprandial satiety. However, nutrigenetic clinical trials demonstrate that the negative impact of this variant on body weight is completely negated when a diet high in soluble fiber and slow-absorbing carbohydrates is implemented. Fiber promotes the release of mechanical and chemical satiety signals in the intestine that bypass the hypothalamic FTO gene defect, allowing these individuals to control their appetite and successfully regulate their weight.

Practical application of nutrigenetics in Oorenji

The true value of understanding the polymorphisms that regulate the response to carbohydrates lies in their practical translation to the user's daily well-being, avoiding simplistic or alarmist interpretations of DNA data.

From polymorphisms to the personalization of the dish

Oorenji's precision platform (https://oorenji.com) is based on this translational application of genomic science. When a user performs their genetic analysis with Oorenji, the artificial intelligence engine does not simply report the presence of isolated polymorphisms such as TCF7L2 or AMY1. The algorithm evaluates the interaction of multiple genetic variants (score polygenic) and cross-references them with the reported symptoms of the user's current lifestyle (daily energy, digestive problems, hunger peaks).

The result is a dynamic nutrition plan that predictively optimizes carbohydrate load and type. If Oorenji's algorithm detects variations that compromise insulin secretion or oral starch digestion, it automatically adapts the user's menu.

• Replace refined carbohydrates with sources rich in insoluble fiber and resistant starch (such as cooked and cooled legumes or tubers with a prebiotic effect).
• Structure the recipes so that carbohydrates are always consumed accompanied by high-quality proteins and healthy fats, slowing gastric emptying and flattening the glucose curve.
• It incorporates nutritional chronobiology techniques, suggesting concentrating carbohydrate intake during the body's peak natural insulin sensitivity hours (morning and midday).

Conclusion: DNA as a metabolic map

Following generic diets that drastically restrict carbohydrates (like extreme keto) or impose fixed, impersonal percentages of macronutrients is an outdated and metabolically risky strategy. Your DNA contains the exact instruction manual for how your body processes sugars and starches.

Using Oorenji's precision tools (https://oorenji.com) allows you to decipher this genetic instruction manual and make health choices truly aligned with your biology. By personalizing your diet based on solid evidence of your polymorphisms, you achieve optimal metabolic flexibility, protect your internal organs from silent inflammation, and attain profound well-being backed by cutting-edge science.

Scientific references

• Perry, GH, Dominy, NJ, Claw, KG, Assgari, AS, … & Stone, AC (2007). Diet and the evolution of human amylase gene copy number variation. Nature Genetics, 39(10), 1256-1260.
• Florez, JC, Jablonski, KA, Bayley, N., Sartori, AM, … & Diabetes Prevention Program Research Group. (2006). TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. New England Journal of Medicine, 355(3), 241-250.
• Frayling, TM, Timpson, NJ, Weedon, MN, Zeggini, E., … & McCarthy, MI (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 316(5826), 889-894.
• Berry, SE, Valdes, AM, Drew, DA, Asnicar, F., … & Spector, TD (2020). Human postprandial responses to food and potential for personalized nutrition. Nature Medicine, 26(6), 964-973.
• Palou, A., & Palou, M. (2021). Nutrigenomics and nutrigenetics: the clinical translation of precision nutrition. Journal of Clinical Medicine, 10(12), 2611.